Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization

Early Human Development

Volumn 87, Issue 9, 2011, Pages 583-588

  Rath, Mirjam E A ^a   Smits Wintjens, Vivianne E H J ^a   Walther, Frans J ^a   Lopriore, Enrico ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Erythrocyte transfusion; Erythropoietin; Fetal erythroblastosis; Folic acid; Iron; Neonatal anemia; Neonatal thrombocytopenia

Indexed keywords

ALPHA TOCOPHEROL; FOLIC ACID; IMMUNOGLOBULIN; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOIMMUNIZATION; ANAPHYLAXIS; ANEMIA; BLEEDING; BLOOD CLOTTING DISORDER; CATHETER INFECTION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; EXCHANGE BLOOD TRANSFUSION; FETUS HYDROPS; FEVER; HUMAN; HYPERBILIRUBINEMIA; HYPERSENSITIVITY; INJECTION SITE DISCOMFORT; INTRAUTERINE BLOOD TRANSFUSION; IRON OVERLOAD; KIDNEY FAILURE; LEUKOPENIA; LUNG EMBOLISM; MORBIDITY; NEUTROPENIA; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; RHESUS INCOMPATIBILITY; SPLENOMEGALY; THROMBOCYTOPENIA; THROMBOSIS;

ANEMIA; BLOOD COAGULATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION, INTRAUTERINE; DIETARY SUPPLEMENTS; ERYTHROBLASTOSIS, FETAL; HUMANS; INFANT, NEWBORN; MORBIDITY; PHOTOTHERAPY; THROMBOCYTOPENIA;

EID: 80052652726     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.07.010     Document Type: Review

References (44)

1. Moise K.J. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008, 13:207-214.
2. Van Kamp I.L., Klumper F.J., Oepkes D., Meerman R.H., Scherjon S.A., Vandenbussche F.P., et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005, 192:171-177.
3. al-Alaiyan S., al Omran A. Late hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med 1999, 27:112-115.
4. De Boer I.P., Zeestraten E.C., Lopriore E., Kanhai H.H., Walther F.J. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol 2008, 198:54.e1-54.e4.
5. Dorn I., Schlenke P., Hartel C. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro. Transfusion 2010, 50:1064-1070.
6. Rath M.E., Smits-Wintjens V.E., Lindenburg I.T., Brand A., Van Kamp I.L., Oepkes D., et al. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang 2011, 100:312-316.
7. Smits-Wintjens V.E., Walther F.J., Lopriore E. Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med 2008, 13:265-271.
8. Rath M.E., Smits-Wintjens V.E., Lindenburg I., Brand A., Oepkes D., Walther F.J., et al. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions. Vox Sang 2010, 99:65-70.
9. New H.V., Stanworth S.J., Engelfriet C.P., Reesink H.W., McQuilten Z.K., Savoia H.F., et al. Neonatal transfusions. Vox Sang 2009, 96:62-85.
10. Dhodapkar K.M., Blei F. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001, 23:69-70.
11. Manoura A., Korakaki E., Hatzidaki E., Saitakis E., Maraka S., Papamastoraki I., et al. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother. Pediatr Hematol Oncol 2007, 24:69-73.
12. Nicaise C., Gire C., Casha P., d'Ercole C., Chau C., Palix C. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion. Fetal Diagn Ther 2002, 17:22-24.
13. Ohls R.K., Wirkus P.E., Christensen R.D. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics 1992, 90:678-680.
14. Ovali F., Samanci N., Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996, 39:831-834.
15. Scaradavou A., Inglis S., Peterson P., Dunne J., Chervenak F., Bussel J. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr 1993, 123:279-284.
16. Wacker P., Ozsahin H., Stelling M.J., Humbert J. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin. Pediatr Hematol Oncol 2001, 18:279-282.
17. Zuppa A.A., Maragliano G., Scapillati M.E., Florio M.G., Girlando P., Noia G., et al. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease. Fetal Diagn Ther 1999, 14:270-274.
18. Zuppa A.A., Alighieri G., Calabrese V., Visintini F., Cota F., Carducci C., et al. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization. J Pediatr Hematol Oncol 2010, 32:e95-101.
19. Ovaly F. Late anaemia in Rh haemolytic disease. Arch Dis Child Fetal Neonatal Ed 2003, 88:F444.
20. Pessler F., Hart D. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin. J Pediatr Hematol Oncol 2002, 24:689-693.
21. Warwood T.L., Ohls R.K., Wiedmeier S.E., Lambert D.K., Jones C., Scoffield S.H., et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 2005, 25:725-730.
22. Warwood T.L., Ohls R.K., Lambert D.K., Leve E.A., Veng-Pedersen P., Christensen R.D. Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates. J Perinatol 2006, 26:636-639.
23. Warwood T.L., Ohls R.K., Lambert D.K., Jones C., Scoffield S.H., Gupta N., et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 2006, 26:296-300.
24. Koury M.J., Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr 2004, 24:105-131.
25. Gandy G., Jacobson W. Influence of folic acid on birthweight and growth of the erythroblastotic infant. III. Effect of folic acid supplementation. Arch Dis Child 1977, 52:16-21.
26. Strelling M.K., Blackledge G.D., Goodall H.B., Walker C.H. Megaloblastic anaemia and whole-blood folate levels in premature infants. Lancet 1966, 1:898-900.
27. Berger H.M., Lindeman J.H., van Zoeren-Grobben D., Houdkamp E., Schrijver J., Kanhai H.H. Iron overload, free radical damage, and rhesus haemolytic disease. Lancet 1990, 335:933-936.
28. Nasrat H.A., Nicolini U., Nicolaidis P., Letsky E.A., Gau G., Rodeck C.H. The effect of intrauterine intravascular blood transfusion on iron metabolism in fetuses with Rh alloimmunization. Obstet Gynecol 1991, 77:558-562.
29. Siddappa A.M., Rao R., Long J.D., Widness J.A., Georgieff M.K. The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology 2007, 92:73-82.
30. Yilmaz S., Duman N., Ozer E., Kavas N., Oren H., Demircioglu F., et al. A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions. J Pediatr Hematol Oncol 2006, 28:290-292.
31. Villalaz R.A., Toner N., Chiswick M.L. Dietary vitamin E and polyunsaturated fatty acid (PUFA) in newborn babies with physiological jaundice. Early Hum Dev 1981, 5:145-150.
32. Alcock G.S., Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002, CD003313.
33. Nasseri F., Mamouri G.A., Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 2006, 27:1827-1830.
34. Elalfy M.S., Elbarbary N.S., Abaza H.W. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn-a prospective randomized controlled trial. Eur J Pediatr 2011, 170:461-467.
35. Smits-Wintjens V.E., Walther F.J., Rath M.E., Lindenburg I.T., Te Pas A.B., Kramer C.M., et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011, 127:680-686.
36. Santos M.C., Sa C.A., Gomes S.C., Camacho L.A., Moreira M.E. High-dose intravenous immunoglobulin therapy for hyperbilirubinemia due Rh hemolytic disease: a randomized clinical trial. Presented at: Pediatric Academic Societies-annual meeting-Vancouver 2010 (E-PAS2010:2851.333) 2010, 143.
37. CLINICAL pathological conference. J Pediatr 1957, 50:490-498.
38. Koenig J.M., Christensen R.D. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 1989, 114:625-631.
39. van den Akker E.S., de Haan T.R., Lopriore E., Brand A., Kanhai H.H., Oepkes D. Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies. Am J Obstet Gynecol 2008, 199:387.e1-387.e4.
40. van den Akker E.S., Klumper F.J., Brand A., Kanhai H.H., Oepkes D. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?. Vox Sang 2008, 95:66-69.
41. Chadd M.A., Gray O.P., Hole D.J. Blood coagulation studies during exchange transfusion. J Obstet Gynaecol Br Commonw 1972, 79:373-376.
42. Hey E., Jones P. Coagulation failure in babies with rhesus isoimmunization. Br J Haematol 1979, 42:441-454.
43. Segal N., Leibovitz E., Juster-Reicher A., Even-Tov S., Mogilner B., Barak Y. Neutropenia complicating Rh-hydrops fetalis: the effect of treatment with recombinant human granulocyte colony-stimulating factor (rhG-CSF). Pediatr Hematol Oncol 1998, 15:193-197.
44. Masumoto A., Masuyama H., Sumida Y., Segawa T., Hiramatsu Y. Successful management of anti-Jra alloimmunization in pregnancy: a case report. Gynecol Obstet Invest 2010, 69:81-83.